Publicacións en colaboración con investigadores/as de Max Planck Institute for Experimental Medicine (12)

2024

  1. Correction to: Pharmacological Modulators of Tau Aggregation and Spreading (Brain Sciences, (2020), 10, 11, (858), 10.3390/brainsci10110858)

    Brain Sciences

2022

  1. Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells

    Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284

2021

  1. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity

    Frontiers in Aging Neuroscience, Vol. 13

  2. Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo

    Neurobiology of Disease, Vol. 151

  3. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells

    Nature Neuroscience, Vol. 24, Núm. 11, pp. 1522-1533

2020

  1. Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization

    Scientific Reports, Vol. 10, Núm. 1

  2. Pharmacological modulators of tau aggregation and spreading

    Brain Sciences, Vol. 10, Núm. 11, pp. 1-29

  3. Synucleinopathies: Where we are and where we need to go

    Journal of Neurochemistry, Vol. 153, Núm. 4, pp. 433-454

2019

  1. Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies

    Cell Reports, Vol. 28, Núm. 1, pp. 65-77.e6

  2. LRRK2, alpha-synuclein, and tau: Partners in crime or unfortunate bystanders?

    Biochemical Society Transactions, Vol. 47, Núm. 3, pp. 827-838

  3. Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved

    Frontiers in Molecular Neuroscience, Vol. 12

  4. Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding

    Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 1, pp. 79-91